Rose is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an editor.
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Review Highlights Need for Further Research, Individualized Treatments for Endometriosis-Associated Infertility
Although there is a clinically recognized association between endometriosis and infertility, the mechanisms behind the association are not fully understood.
New Clinical Guidelines Recommend Finerenone for CKD Associated With T2D
Updated Kidney Disease: Improving Global Outcomes guidelines and a consensus report with the American Diabetes Association support the use of finerenone in certain patients who have chronic kidney disease (CKD) that may be linked to type 2 diabetes (T2D).
Virtual Assistants in Teledermatology May Improve Quality of Life for Patients With Psoriasis
A prospective study found that patients and providers saw benefits while using a virtual assistant integrated into a teledermatology program.
Do Automated Insulin Delivery Systems Have a Place in T2D Treatment?
Although automated insulin delivery systems have gained traction in type 1 diabetes, further research is needed to determine the feasibility of using such systems for patients with type 2 diabetes.
Some Patients With CAD Experience Sustained Remission After Sutimlimab Discontinuation
A research letter published in Blood Advances details the first clinical evidence of sustained hematologic remission for cold agglutinin disease (CAD) after sutimlimab treatment discontinuation.
Patients With Psoriasis Prescribed Biologics Face Care Delays From Prior Authorization
A brief report found that a need for prior authorization affected biologic approval wait times for patients with psoriasis, especially those with private insurance.
Study Highlights Value of PROs in Children With Sickle Cell Disease During Acute Pain Episodes
Sufficiently powered studies are necessary to investigate associations between clinical measures and patient-reported outcomes (PROs) in children with sickle cell disease experiencing acute pain episodes, according to a recent study.
Report Suggests Best Practices for Care of Pediatric Sickle Cell Disease
A panel of specialists proposed 26 essential elements for comprehensive pediatric sickle cell disease care, laying groundwork for standardized guidelines and the establishment of accredited care centers in the future.
Strategies for Managing Autoimmune Complications in CLL
While chronic lymphocytic leukemia (CLL) typically progresses slowly, awareness of rare but potentially serious complications is crucial to improve outcomes.
Shorter Time to Treatment Is Associated With Worse OS in Multiple Myeloma, Study Finds
The study highlights a need for further research into potential contributors, including the possibility that sicker patients may receive more prompt treatment.
Real-World Study of Voxelotor for Sickle Cell Disease Shows Safety, Efficacy Similar to Clinical Trials
Over the course of voxelotor treatment, hemoglobin levels and hemolysis markers improved, with results sustained over the treatment period.
NSAIDs May Be Safe for Use in Hemophilia, but More Research Is Needed
The hesitation to prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to patients with hemophilia is not supported by current research, based on a recently published review, but the available studies had significant limitations.
Need for More Research Into Chronic GVHD After Allogeneic HSCT Highlighted in New Review
Although the understanding of chronic graft-versus-host disease (GVHD) has improved in recent years, more work is needed to facilitate personalized treatments for patients after hematopoietic stem cell transplantation (HSCT).
Sickle Cell Disease With Recurrent Vaso-Occlusive Crises Carries a Substantial Economic Burden, Study Finds
The analysis emphasizes the association between vaso-occlusive crisis frequency and health care costs, which are inflated largely due to inpatient visits.
Cost-Savings Model Estimates Reduced Economic Burden With Gene Therapy for Hemophilia A
Gene therapy is a novel approach to hemophilia A treatment that carries a substantial cost up front but may lead to cost savings compared with current prophylaxis agents in the long run.
Telenursing May Lead to Lower Symptom-Related Distress in Lung Cancer
The findings suggest telenursing between in-person visits may help reduce distress related to symptoms in patients who have lung cancer.
Non–Driver Gene Mutations May Hold Predictive Value in ET and PV
A recent study supports the notion that non–driver mutations in essential thrombocythemia (ET) and polycythemia vera (PV) have predictive value and found that a proposed international prognostication model may be useful for Japanese patients.
Report Details Rare Case of Acquired Hemophilia A Secondary to Immune Checkpoint Inhibition
This rare immune-related adverse event has only been previously reported 4 times in the context of immune checkpoint inhibitor (ICI) treatment.
Case Report Describes Thrombocytopenia Secondary to Iron-Deficiency Anemia
A recently published report describes the diagnosis and treatment of a case of iron-deficiency anemia–associated thrombocytopenia secondary to recurrent nosebleeds.
Meta-Analysis Supports Immune Checkpoint Inhibitors in Frontline NSCLC Treatment
Immune checkpoint inhibitors, either alone or in combination with chemotherapy, were associated with better outcomes in non–oncogene-addicted non–small cell lung cancer (NSCLC).
Diagnosing and Managing Hemophilia Carriers in Thailand Stressed in New Study
A study of women and girls from families with hemophilia in Thailand assessed the emotional impact of a carrier diagnosis and emphasized the value of comprehensive management.
Clarifying Different Characteristics of Erythrocytosis
JAK2-unmutated erythrocytosis has a variety of etiologies, and identifying the underlying cause may prove helpful in cases where it is secondary to another condition such as polycythemia vera.
Improved Surveillance, Registry Data Could Improve Outcomes in Sickle Cell Disease
Population-based data is a crucial aspect to evaluating current care quality and improving outcomes for patients with sickle cell disease.
A Large Proportion of Bleeds Are Untreated, Unreported in Hemophilia A
Untreated bleeds often go undocumented during clinical trials, but reporting these bleeding events could provide additional insight into therapy efficacy.
Stem Cells Highlighted as Potential Therapeutic Option in Huntington Disease
Although no pharmacological treatment offers long-term efficacy or extends survival with Huntington disease at this point, research suggests that stem-cell therapy holds promise in this and other neurodegenerative diseases.
Review Underscores Potential and Obstacles of Universal CAR T-Cell Therapy
Despite the obstacles and risks, the review authors conclude that universal chimeric antigen receptor (CAR) T-cell therapy has the potential to play a key role and mitigate some of the limitations associated with autologous CAR T-cell therapy in cancer treatment.
Review Addresses Proper Applications of Sutimlimab in Cold Agglutinin Disease
A review published in the journal Immunotherapy summarizes the applications of sutimlimab and emphasizes the importance of individualizing treatment for patients with cold agglutinin disease.
Applications, Future Directions of BTK Inhibitors in Blood Cancers and Autoimmune Disorders
A recent review summarized the current landscape of Bruton tyrosine kinase (BTK) inhibitors in both hematological cancers and inflammatory disorders.
Advances and Limitations in CD20-Targeted CAR T-Cell Therapy
The review concludes that CD20-targeted chimeric antigen receptor (CAR) T-cell therapy is an option worth exploring, despite potential safety concerns that warrant more extensive research.
Model Predicts Early Disease Progression for Patients With Multiple Myeloma
The model was found to be predictive and may help identify patients with multiple myeloma at a high risk of early disease progression.
2 Clarke Drive Cranbury, NJ 08512